Home LiteratureArticle Details
PMID: 2938594 Published · ppublish English Journal Article

Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction.

Atherosclerosis ·Vol. 59 ·No. 2 ·1986-02-00 ·Pages 199-204

Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M

Abstract

Attempts were made to prepare antisera monospecific for Lp(a) lipoprotein and to investigate the distribution of subjects according to plasma levels of Lp(a) in Japanese controls and patients with coronary heart disease or cerebral infarction. Positive plasma reactions to the double diffusion test for Lp(a) (Ouchterlony) were observed in 32.3% of the healthy Japanese subjects, which is similar to results previously reported in western countries. The plasma threshold level of 17 mg/dl was considered an appropriate point for dividing subjects into positive and negative groups depending on reactions to the double diffusion test. When subjects were divided into two groups at 17 mg/dl, a significant association was found between a high plasma level of Lp(a) and either coronary heart disease or cerebral infarction in the distribution of the cortical artery. These results suggest that Lp(a) may play an important part as a risk factor for coronary heart disease and cerebral infarction.

MeSH Terms
Aged Arteriosclerosis/blood,etiology Cerebral Infarction/blood,etiology Cholesterol/blood Coronary Disease/blood,etiology Female Humans Immunodiffusion Lipoprotein(a) Lipoproteins/blood Male Middle Aged Risk
Chemicals
Lipoprotein(a) Lipoproteins Cholesterol
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Murai A
Miyahara T
Fujimoto N
Matsuda M
Kameyama M
Article Info
Journal
Atherosclerosis
Abbr.
Atherosclerosis
ISSN
0021-9150
Published
1986-02-00
Pages
199-204
Language
English
Region
Ireland
NLM ID
0242543
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com